| Meridian is a fully integrated life science company that manufactures, markets and distributes a broad range of innovative diagnostic test kits, purified reagents and related products and offers biopharmaceutical enabling technologies. Utilizing a variety of methods, these products provide accuracy, simplicity and speed in the early diagnosis and treatment of common medical conditions, such as gastrointestinal, viral, urinary and respiratory infections. Meridian diagnostic products are used out... More >> |
| | | Date | Title | | | 01/21/10 | Meridian Bioscience Reports Record First Quarter Sales and Operating Results, Declares Regular Cash Dividend, and Reaffirms Fiscal 2010 Guidance| CINCINNATI, Jan 21, 2010 (BUSINESS WIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO):
GENERAL HIGHLIGHTS
Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ: VIVO) today:
reported record first quarter net sales of $42.5 million, an increase of 24%, over the same period of the prior fiscal year;
reported record first quarter operating income of $13.8 million, an increase of 13%, over the same period of the prior fiscal year;
reported record first quarter earnings and diluted earnings... |
|  | | 11/12/09 | Meridian Bioscience Reports Record Fiscal 2009 Operating Results, Increases Regular Cash Dividend Rate, and Reaffirms Guidance| CINCINNATI--(BUSINESS WIRE)--Nov. 12, 2009--
Meridian Bioscience, Inc. (NASDAQ: VIVO):
GENERAL HIGHLIGHTS
Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ: VIVO) today:
reported record fourth quarter and full-year fiscal 2009 net sales of
$42.5 million and $148.3 million, respectively, increases of 16% and
6%, respectively, over the same periods of the prior fiscal year;
reported recor... |
| | | 09/30/09 | Meridian Bioscience Europe Announces Agreement to Distribute Test For GI Disease| CINCINNATI--(BUSINESS WIRE)--Sep. 30, 2009--
Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ: VIVO) announced
today that Meridian Bioscience Europe srl, Milan, Italy has signed an
agreement with BÜHLMANN Laboratories AG, Schönenbuch, Switzerland for
distribution in Italy of an innovative test for inflammatory conditions
of the intestine, Quantum Blue® Calprotectin. The test which
detects calprotectin, a GI inflammatory marker, is a fundamental to... |
| | | 09/17/09 | Meridian Bioscience Granted Special 510(k) Clearance to Add 2009 H1N1 Influenza A Virus Analytical Sensitivity Claim to the TRU FLU(R) Test Package Insert| CINCINNATI--(BUSINESS WIRE)--Sep. 17, 2009--
Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ:VIVO) today
announced that the company has been granted a Special 510(k) clearance
to update the TRU FLU package insert to include analytical sensitivity
claims with two strains of 2009 H1N1 virus cultured from positive
respiratory specimens. TRU FLU is a rapid test which identifies
influenza A and B in human specimens.
Meridian’s T... |
| |
|
| | * Data collected 02/10/10 - 02/17/10 |
|
|
|
| |
